397 related articles for article (PubMed ID: 26859610)
21. [Effectiveness and security of venlafaxine XR in the treatment of major depression].
Illescas-Rico R; Páez-Agraz F; Arreola-Chávez F; Verduzco-Fragoso W; García-Rosas FA; Luna-Soria F
Rev Med Inst Mex Seguro Soc; 2005; 43(6):473-8. PubMed ID: 16398952
[TBL] [Abstract][Full Text] [Related]
22. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
Simon JS; Aguiar LM; Kunz NR; Lei D
J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
24. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
25. Validation of Computerized Adaptive Testing in an Outpatient Nonacademic Setting: The VOCATIONS Trial.
Achtyes ED; Halstead S; Smart L; Moore T; Frank E; Kupfer DJ; Gibbons R
Psychiatr Serv; 2015 Oct; 66(10):1091-6. PubMed ID: 26030317
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of depression after spinal cord injury: a meta-analysis.
Williams R; Murray A
Arch Phys Med Rehabil; 2015 Jan; 96(1):133-40. PubMed ID: 25220943
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury.
Kennedy RE; Livingston L; Riddick A; Marwitz JH; Kreutzer JS; Zasler ND
J Head Trauma Rehabil; 2005; 20(6):512-26. PubMed ID: 16304488
[TBL] [Abstract][Full Text] [Related]
28. Preliminary Psychometric Evaluation of the Hamilton Depression Rating Scale in Methamphetamine Dependence.
Hellem T; Scholl L; Sung YH; Ferguson H; McGlade E; Yurgelun-Todd D; Renshaw P; Hildreth L
J Dual Diagn; 2017; 13(4):305-311. PubMed ID: 28820669
[TBL] [Abstract][Full Text] [Related]
29. Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
McIntyre A; Paisley D; Kouassi E; Gendron A
Arthritis Rheumatol; 2014 Feb; 66(2):451-61. PubMed ID: 24504819
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder.
Fagiolini A; Albert U; Ferrando L; Herman E; Muntean C; Pálová E; Cattaneo A; Comandini A; Di Dato G; Di Loreto G; Olivieri L; Salvatori E; Tongiani S; Kasper S
Int Clin Psychopharmacol; 2020 May; 35(3):137-146. PubMed ID: 31972628
[TBL] [Abstract][Full Text] [Related]
31. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
[TBL] [Abstract][Full Text] [Related]
32. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
Jamerson BD; Krishnan KR; Roberts J; Krishen A; Modell JG
Psychopharmacol Bull; 2003; 37(2):67-78. PubMed ID: 14566216
[TBL] [Abstract][Full Text] [Related]
33. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
34. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
35. Measuring depression after spinal cord injury: Development and psychometric characteristics of the SCI-QOL Depression item bank and linkage with PHQ-9.
Tulsky DS; Kisala PA; Kalpakjian CZ; Bombardier CH; Pohlig RT; Heinemann AW; Carle A; Choi SW
J Spinal Cord Med; 2015 May; 38(3):335-46. PubMed ID: 26010968
[TBL] [Abstract][Full Text] [Related]
36. Association of internet use and depression among the spinal cord injury population.
Tsai IH; Graves DE; Lai CH; Hwang LY; Pompeii LA
Arch Phys Med Rehabil; 2014 Feb; 95(2):236-43. PubMed ID: 23973443
[TBL] [Abstract][Full Text] [Related]
37. Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder.
McIntyre RS; Agid O; Biesheuvel E; Purushottamahanti P
CNS Spectr; 2024 Jun; 29(3):206-214. PubMed ID: 38685594
[TBL] [Abstract][Full Text] [Related]
38. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury.
Fann JR; Bombardier CH; Dikmen S; Esselman P; Warms CA; Pelzer E; Rau H; Temkin N
J Head Trauma Rehabil; 2005; 20(6):501-11. PubMed ID: 16304487
[TBL] [Abstract][Full Text] [Related]
39. Spinal Cord Injury-Functional Index/Assistive Technology Short Forms.
Slavin MD; Ni P; Tulsky DS; Kisala PA; Heinemann AW; Charlifue S; Fyffe DC; Graves DE; Marino RJ; Morse LR; Rosenblum D; Tate D; Worobey LA; Dawson MB; Jette AM
Arch Phys Med Rehabil; 2016 Oct; 97(10):1745-1752.e7. PubMed ID: 27133356
[TBL] [Abstract][Full Text] [Related]
40. Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder.
Güzel Özdemir P; Boysan M; Smolensky MH; Selvi Y; Aydin A; Yilmaz E
J Clin Psychiatry; 2015 May; 76(5):e645-54. PubMed ID: 26035199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
